Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Steroids and the Nasal Ocular Response

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria~1. Males and females between 18 and 45 years of age.~2. History of grass and/or ragweed allergic rhinitis.~3. Positive skin test to grass and/or ragweed antigen.~4. Positive response to screening nasal challenge.~Exclusion Criteria~1. Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.~2. Pregnant or lactating women.~3. Upper respiratory infection within 14 days of study start.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).